Compositions and methods for enhancing the efficacy of IL-2 mediated immune responses

Details for Australian Patent Application No. 2007271398 (hide)

Owner Merck Patent GmbH

Inventors Gillies, Stephen D.

Agent Davies Collison Cave

Pub. Number AU-A-2007271398

PCT Pub. Number WO2008/003473

Priority 60/856,139 02.11.06 US; 60/818,741 06.07.06 US

Filing date 4 July 2007

Wipo publication date 10 January 2008

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 14/55 (2006.01) Peptides having more than 20 amino acids

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/003473 Priority application(s): WO2008/003473

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007271402-Highly porous magnetic temporary fixed bed

2007271373-Lowfat, waterin-oil confectionery emulsion